Figure 12. MAGE-A3 regulates tumour stemness and proliferation through the PI3K/AKT pathway. (A, B) Western blot and cellular immunofluorescence techniques were used to detect the expression of PI3K/AKT and tumour stem cell protein biomarkers under different grouping treatments. (C, D) EDU assays were used to detect the proliferation ability of cells under different grouping treatments. (E, F) CCK-8 assays were used to detect the proliferation ability of cells under different grouping treatments.